[EX 1 Announcement dated October 10, 2016 in respect of Mixed-ownership Reform. changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunications services by the central government of the PRC; changes in telecommunications and related technologies and]
[FOR RELEASE October 11, 2016 China Biologic Receives CFDA Clinical Trial Approval for Human Antithrombin III BEIJING, China – October 11, 2016 – ATIII is intended to treat hereditary and acquired ATIII deficiency in connection with surgical or obstetrical procedures, and to treat thromboembolism. No]
[EX 1 Announcement dated October 10, 2016 in respect of Mixed-ownership Reform. changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunications services by the central government of the PRC; changes in telecommunications and related technologies and]
[To Stockholders of Carmike Cinemas, Inc.: On July 24, 2016, AMC Entertainment Holdings, Inc., referred to as "AMC," entered into an Amended and Restated Agreement and Plan of Merger, referred to as the "amended and restated merger agreement," with Carmike Cinemas, Inc., referred to as "Carmike," and]
[Sinovac Schedules 2016 Annual Meeting of Shareholders BEIJING , Sept. 30, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will hold its 2016 Annual Meeting of Shareholders on Monday, November 7, 2016 at 9:00 ]
[To Stockholders of Carmike Cinemas, Inc.: On July 24, 2016, AMC Entertainment Holdings, Inc., referred to as "AMC," entered into an Amended and Restated Agreement and Plan of Merger, referred to as the "amended and restated merger agreement," with Carmike Cinemas, Inc., referred to as "Carmike," and]
[Sinovac Schedules 2016 Annual Meeting of Shareholders BEIJING , Sept. 30, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will hold its 2016 Annual Meeting of Shareholders on Monday, November 7, 2016 at 9:00 ]
[____________________ POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts ___________________ DAQO NEW ENERGY CORP. (Exact name of issuer of deposited securities as specified in its charter)]
